MedTrace Logo

Immunonutrition in Ulcerative Colitis

NCT03594708 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-07-20

No results posted yet for this study

Summary

This study tests the hypothesis that a supplement that combines a functional fiber, long chain omega-3 polyunsaturated fatty acids (PUFAs), vitamin D3, vitamin E, and zinc will reduce clinical symptoms, decrease pro-inflammatory cytokines in the blood and ergo decrease inflammation, promote beneficial microbial activity in the colon, and help recovery of the intestinal mucosa of ulcerative colitis (UC) patients compared with a placebo.

Conditions

Interventions

DIETARY_SUPPLEMENT

Nutrition supplement

Fermentable fiber, omega-3 fatty acid, vitamin D3, vitamin E, zinc

DIETARY_SUPPLEMENT

Placebo supplement

rice starch, light olive oil, vegetable oil

Sponsors & Collaborators

  • Baptist Memorial Health Care Corporation

    lead OTHER

Principal Investigators

  • Randal K Buddington, PhD · The University of Memphis

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03594708 on ClinicalTrials.gov